Upgrade to SI Premium - Free Trial

Karyopharm Therapeutics (KPTI) PT Lowered to $20 at Wedbush

August 4, 2020 1:44 PM
Wedbush analyst David Nierengarten lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles